Login

SPECTRUM PHARMACEUTICALS INC 3 SEC Filings

Filed On Filing
12 May 2022 Form 3: Bradrick Brittany, Director

No securities owned

24 Mar 2022 Form 3: Lim Juhyun, Director

No securities owned

14 Dec 2020 Form 3: Brennan Nora, Director

No securities owned

27 Apr 2020 Form 3: Fischer Seth H. Z., Director

No securities owned

02 Jul 2019 Form 3: Czerepak Elizabeth, Director

No securities owned

21 Jun 2019 Form 3: Lebel Francois, Chief Medical Officer

Holds 70,250 shares of Common Stock, $0.001 par value

14 Nov 2018 Form 3: Vacirca Jeff L, Director

Holds 10,300 shares of Common Stock, $0.001 par value

18 Jun 2018 Form 3: Welles Bernice R, Director

No securities owned

18 Jun 2018 Form 3: McGahan Keith M, SVP and Chief Legal Officer

No securities owned

05 Mar 2018 Form 3: Ashton William, Director

No securities owned

27 Dec 2017 Form 3: Riga Thomas J, Chief Operating Officer

Holds 151,696 shares of Common Stock, $0.001 par value

25 Sep 2014 Form 3: Spectrum Pharmaceuticals Inc, 10% owner and 1 other · CASI Pharmaceuticals, Inc (DE)

Holds 3,228,627 shares of Common Stock

02 Jul 2013 Form 3: Vyas Dolatrai, Director
01 Jul 2013 Form 3: Cohen Raymond W, Director

No securities owned

05 Jun 2013 Form 3: Gustafson Kurt A, EVP & Chief Financial Officer

No securities owned

24 Apr 2013 Form 3: Turgeon Joseph W., Chief Commercial Officer

Holds 25,000 shares of Common Stock, $0.001 Par Value

24 Apr 2013 Form 3: Allen Lee F Md PhD, Chief Medical Officer

Holds 30,000 shares of Common Stock, $0.001 Par Value

11 Sep 2012 Form 3: Keller Joseph Kenneth, EVP & Chief Operating Officer

Holds 8,000 shares of Common Stock, $.001 Par Value

06 Sep 2012 Form 3: Spectrum Pharmaceuticals Inc, 10% owner and 1 other · ALLOS THERAPEUTICS INC

Holds 117,769,357 shares of Common Stock

03 Apr 2012 Form 3: Gagnon Gilles, Director

Holds 25,000 shares of Common Stock, $.001 Par Value

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support